
Gigi Georgiana Huang
Examiner (ID: 12753)
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621 |
| Total Applications | 781 |
| Issued Applications | 217 |
| Pending Applications | 66 |
| Abandoned Applications | 506 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12177375
[patent_doc_number] => 20180036311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'TREATMENT FOR HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES (HNPP)'
[patent_app_type] => utility
[patent_app_number] => 15/651931
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13918
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651931 | Treatment for hereditary neuropathy with liability to pressure palsies (HNPP) | Jul 16, 2017 | Issued |
Array
(
[id] => 14622015
[patent_doc_number] => 20190224375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/317101
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317101 | METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS | Jul 12, 2017 | Abandoned |
Array
(
[id] => 14273295
[patent_doc_number] => 20190133932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Compositions, Methods and Kits for Treating a Contact Lens
[patent_app_type] => utility
[patent_app_number] => 16/096603
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096603 | Compositions, methods and kits for treating a contact lens | Apr 27, 2017 | Issued |
Array
(
[id] => 17539781
[patent_doc_number] => 11304884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Methods, compositions and uses relating thereto
[patent_app_type] => utility
[patent_app_number] => 16/095593
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8263
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095593 | Methods, compositions and uses relating thereto | Apr 20, 2017 | Issued |
Array
(
[id] => 11834561
[patent_doc_number] => 20170216281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'OPTICAL CORRECTION'
[patent_app_type] => utility
[patent_app_number] => 15/489950
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3060
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489950 | Optical correction | Apr 17, 2017 | Issued |
Array
(
[id] => 14182741
[patent_doc_number] => 20190111075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => STORAGE-STABLE OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/089715
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089715 | Storage-stable ophthalmic composition | Apr 11, 2017 | Issued |
Array
(
[id] => 11820463
[patent_doc_number] => 20170209400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'METHODS AND TOPICAL FORMULATIONS FOR TREATING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 15/484058
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9104
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484058
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/484058 | METHODS AND TOPICAL FORMULATIONS FOR TREATING INFLAMMATION | Apr 9, 2017 | Abandoned |
Array
(
[id] => 12178644
[patent_doc_number] => 20180037579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/462326
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 59645
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462326 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | Mar 16, 2017 | Abandoned |
Array
(
[id] => 15320769
[patent_doc_number] => 20200000714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => OPHTHALMIC COMPOSITION COMPRISING PVP-I
[patent_app_type] => utility
[patent_app_number] => 16/092173
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092173 | OPHTHALMIC COMPOSITION COMPRISING PVP-I | Feb 16, 2017 | Pending |
Array
(
[id] => 11588357
[patent_doc_number] => 20170112768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/398207
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12305
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398207
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398207 | DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF | Jan 3, 2017 | Abandoned |
Array
(
[id] => 11588445
[patent_doc_number] => 20170112856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/397166
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8151
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397166 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER | Jan 2, 2017 | Abandoned |
Array
(
[id] => 11647792
[patent_doc_number] => 20170143693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/373604
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33897
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/373604 | COMPOSITIONS AND METHODS FOR TREATMENT | Dec 8, 2016 | Abandoned |
Array
(
[id] => 11647791
[patent_doc_number] => 20170143692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/372863
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33872
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372863 | COMPOSITIONS AND METHODS FOR TREATMENT | Dec 7, 2016 | Abandoned |
Array
(
[id] => 13586169
[patent_doc_number] => 20180344633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => USE OF ENZYME-MODIFIED ISOQUERCITRIN
[patent_app_type] => utility
[patent_app_number] => 15/780828
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780828 | USE OF ENZYME-MODIFIED ISOQUERCITRIN | Dec 1, 2016 | Abandoned |
Array
(
[id] => 12997585
[patent_doc_number] => 10022439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Allergen desensitization method
[patent_app_type] => utility
[patent_app_number] => 15/367078
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7740
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367078 | Allergen desensitization method | Nov 30, 2016 | Issued |
Array
(
[id] => 11647790
[patent_doc_number] => 20170143691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/364935
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33890
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364935
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364935 | COMPOSITIONS AND METHODS FOR TREATMENT | Nov 29, 2016 | Abandoned |
Array
(
[id] => 11647789
[patent_doc_number] => 20170143690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/357237
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33891
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357237 | COMPOSITIONS AND METHODS FOR TREATMENT | Nov 20, 2016 | Abandoned |
Array
(
[id] => 11527150
[patent_doc_number] => 20170087127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)'
[patent_app_type] => utility
[patent_app_number] => 15/343859
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6379
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343859 | Composition for nonalcoholic fatty liver disease (NAFLD) | Nov 3, 2016 | Issued |
Array
(
[id] => 11434693
[patent_doc_number] => 20170035714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Oral Dosage forms having a High Loading of a Gabapentin Prodrug'
[patent_app_type] => utility
[patent_app_number] => 15/294457
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16300
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/294457 | Oral Dosage forms having a High Loading of a Gabapentin Prodrug | Oct 13, 2016 | Abandoned |
Array
(
[id] => 11381526
[patent_doc_number] => 20170007581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/273456
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20182
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273456
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273456 | CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES | Sep 21, 2016 | Abandoned |